Navigation Links
Cumberland Pharmaceuticals to Announce Second Quarter 2009 Financial Results on August 27, 2009
Date:8/24/2009

NASHVILLE, Tenn., Aug. 24 /PRNewswire-FirstCall/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) announced today that it will report second quarter 2009 financial results before the market opens on Thursday, August 27, 2009. A conference call and live Internet webcast will be held on Thursday, August 27, 2009 at 10:00 a.m. Eastern Time to discuss the results.

To participate on the call, please dial 877-604-9672 (for U.S. callers) or 719-325-4909 (for international callers). A rebroadcast of the teleconference will be available for one week and can be accessed by dialing 888-203-1112 (for U.S. callers) or 719-457-0820 (for international callers). The passcode for the rebroadcast is 7834064. The live webcast and rebroadcast can be accessed via Cumberland Pharmaceuticals' website at http://investor.shareholder.com/cpix/events.cfm.

Cumberland Pharmaceuticals Inc. is a Tennessee-based specialty pharmaceutical company focused on the acquisition, development and commercialization of branded prescription products. The Company's primary target markets include hospital acute care and gastroenterology. Cumberland markets Acetadote(R) for the treatment of acetaminophen poisoning and Kristalose(R), a prescription laxative. The Company also recently received FDA approval for Caldolor(R), the first injectable treatment for pain and fever available in the United States, and is preparing for the commercial launch of that product. Cumberland is dedicated to providing innovative products which improve quality of care for patients. The Company completed its initial public offering of common stock in August 2009.

For more information on Cumberland Pha
'/>"/>

SOURCE Cumberland Pharmaceuticals Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Cumberland Pharmaceuticals Announces Appointments
2. Orion ICG, LLC Announces Acquisition of Cumberland Therapy Services, Inc.
3. The Rossbacher Law Firm, Hagens Berman Sobol Shapiro LLP, Wilentz Goldman & Spitzer, P.A., Reed Smith LLP and Thompson Hine LLP, Announce the Proposed Settlement of a Class Action Lawsuit Concerning Estratest and Solvay Pharmaceuticals, Inc.
4. NovaBay Pharmaceuticals to Present New Pre-Clinical Data on Lead Anti-Infective Compound for use in Onychomycosis at the 2009 IDSA Annual Meeting
5. Warner Chilcott Acquires P&Gs Global Pharmaceuticals Business
6. Valeant Pharmaceuticals Announces Preliminary Results From Its Phase IIa Retigabine Study for the Treatment of Postherpetic Neuralgia (PHN)
7. Sound Pharmaceuticals Receives an Office of Naval Research Award for Its Hearing Loss Research and Development
8. Adamas Pharmaceuticals Raises $40 Million in Series D Financing
9. Transcept Pharmaceuticals Reports Second Quarter 2009 Financial Results
10. Hisamitsu Pharmaceutical Announces Expiration of HSR Waiting Period for Its Proposed Acquisition of Noven Pharmaceuticals
11. Mylan Pharmaceuticals Receives Final FDA Report and Reaffirms Its 48-Year Exemplary Record of Quality
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... don,t worry, it,s a good thing! As scientists have ... bad. Many active enzymes and bacteria are merely benign, ... important part of our digestive system or can help ... an opportunistic yeast pathogen and model organism for research, ... ecosystem. However, when our immune system is stressed on ...
(Date:9/18/2014)... Non-governmental stakeholders will convene a one-day conference at ... George Washington University on September 25, 2014 to discuss ... towards GHSA implementation. The purpose of this event is ... over the next five years, including action plans to ... 2014 launch of the GHSA, international organizations and more ...
(Date:9/18/2014)... (September 18, 2014) The National Institutes of ... from a four-year, $1.3 million grant to the Los ... the research and development of a vaccine to protect ... Methicillin-resistant Staphylococcus aureus (MRSA). , The ... the NIH awarded the grant to LA BioMed infectious ...
(Date:9/18/2014)... DURHAM, N.C. Dangerous new pathogens such as the ... even ancient scourges such as the bubonic plague are ... body responds to infections. , In a study published ... , researchers at Duke Medicine and Duke-NUS Graduate Medical ... cause bubonic plague hitchhike on immune cells in the ...
(Date:9/18/2014)... ChopChop founder Sally Sampson is challenging former ... Massachusetts’s winner of the First Lady’s Healthy Lunchtime Challenge, to ... Eastern bean dip. Watch as Bill and Yonah cook side-by-side ... own healthy dips at home. The cooking demonstration will take ... Talk About Food Festival in Copley Square on September ...
Breaking Medicine News(10 mins):Health News:Everything in moderation: Micro-8 to study regulating pathogens in space 2Health News:Everything in moderation: Micro-8 to study regulating pathogens in space 3Health News:Non-governmental stakeholders to discuss the Global Health Security Agenda 2Health News:LA BioMed receives NIH grant to study vaccine for hospital-acquired infections 2Health News:New insights on an ancient plague could improve treatments for infections 2Health News:Award-Winning Cooking Magazine for Kids Challenges Former White House Pastry Chef and 10-Year-Old Chef to Cook Up a Healthy Snack 2Health News:Award-Winning Cooking Magazine for Kids Challenges Former White House Pastry Chef and 10-Year-Old Chef to Cook Up a Healthy Snack 3
... surveillance, planning and interagency coordinationWASHINGTON, May 8 Environmental ... the Natural Resources Defense Council (NRDC) praised legislation introduced ... climate change. The bill is sponsored by the ... Commerce Committee,s Subcommittee on Health , U.S. Rep. ...
... This Sunday, individuals all over the nation ... women who gave them life: their mothers. While people in ... International Breast Milk Project (IBMP) hopes to inspire some to ... that helps mothers in the United States send their breast ...
... Kaiser Foundation Health Plan, Inc., Kaiser Foundation Hospitals and ... $10.6 billion for the quarter ended March 31, 2009, ... year. Operating income in the first quarter was ... of 2008. Declines in the financial markets impacted ...
... May 8 Misonix, Inc. (Nasdaq: MSON ... technology, which in Europe is used for the ablation ... has entered into a definitive, 5-year distribution agreement with ... in Barcarena, Portugal, expanding on and replacing a previous ...
... - Majority have not changed their behavior or lifestyle ... May 8 A new national study among 1,477 ... become less concerned about the impact that the H1N1 ... http://www.newscom.com/cgi-bin/prnh/20071204/NYTU133LOGO )Results ...
... Family, Inc. (Nasdaq: AFAM ), a leading regional ... Yarmuth, President and Chief Executive Officer, and Steve Guenthner, Senior ... at two upcoming investor conferences. The first presentation will ... Stock Conference at the Four Seasons Hotel in Chicago, IL., ...
Cached Medicine News:Health News:New Bill to Fund Climate Change and Public Health Preparedness Praised by Environmental and Health Groups 2Health News:New Bill to Fund Climate Change and Public Health Preparedness Praised by Environmental and Health Groups 3Health News:New Bill to Fund Climate Change and Public Health Preparedness Praised by Environmental and Health Groups 4Health News:International Breast Milk Project Helps Mothers Worldwide 2Health News:Kaiser Foundation Health Plan and Hospitals Report First Quarter 2009 Financial Results 2Health News:Kaiser Foundation Health Plan and Hospitals Report First Quarter 2009 Financial Results 3Health News:Misonix Announces New HIFU Distribution Agreement For Portugal 2Health News:Misonix Announces New HIFU Distribution Agreement For Portugal 3Health News:Docs Are Becoming Less Concerned About H1N1 Swine Flu 2Health News:Docs Are Becoming Less Concerned About H1N1 Swine Flu 3Health News:Docs Are Becoming Less Concerned About H1N1 Swine Flu 4Health News:Almost Family to Present at Two Upcoming Conferences 2
(Date:9/18/2014)... 2014   Fruit Street Health (Fruit Street), ... round of funding. The round, which ... series of individual investors, the majority of whom are ... initial round are; Houston Cardiology Consultants Partner Asif ... Childs, Rapha Family Medicine Practice Owner Frances Ilozue ...
(Date:9/18/2014)... N.J. , Sept. 18, 2014  ADM ... Gianluca DeNovi , Ph.D. to its corporate Advisory ... is an instructor at the Harvard Medical School ... of Rome.  He received his Masters degree in ... Control Systems from the University of Bologna. After spending ...
(Date:9/18/2014)... MEETING, Pa. , Sept. 18, 2014 ... trial solutions, was recognized as the Disruptive ... for its ePharmaONE cloud-based eClinical platform. This ... and electronic trial master file (eTMF), a ... solution, and ePharmaSolutions, ReferralPlus+ patient screening and ...
Breaking Medicine Technology:Fruit Street Health Secures First Round Of Seed Funding Led By Group Of Medical Industry And Technology Leaders 2Fruit Street Health Secures First Round Of Seed Funding Led By Group Of Medical Industry And Technology Leaders 3ADM Tronics Appoints Gianluca DeNovi, Ph.D. To Advisory Board 2ADM Tronics Appoints Gianluca DeNovi, Ph.D. To Advisory Board 3ePharmaSolutions Named 2014 Disruptive Innovator of the Year for its ePharmaONE eClinical Platform 2ePharmaSolutions Named 2014 Disruptive Innovator of the Year for its ePharmaONE eClinical Platform 3
For use with catalog #0540....
Lupus Anticoagulant-Sensitive APTT Reagent.Cephalin with particulate activator (silica), freeze-dried....
Antigenic Total Protein S, ELISA Method...
Colorimetric Assay of Antithrombin III Activity by STA© Analyzers. Bovine thrombin ~12NIH units/mL, freeze-dried....
Medicine Products: